![Geoffrey A. Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey A. Strange is currently the Chief Research & Strategy Officer at EchoIQ Ltd. and the Chief Medical Officer at LTR Pharma Ltd. Previously, he served as the Chief Executive Officer of The Pulmonary Hypertension Society of Australia & New Zealand from 2009 to 2021.
He also worked as the Global Medical Director at Anteris Technologies Ltd.
| Bedrijven | Functie | Begin |
|---|---|---|
| VERILUMA | Hoofd Techniek/Wetenschap/O&O | - |
| LTR PHARMA LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
| Bedrijven | Functie | Einde |
|---|---|---|
The Pulmonary Hypertension Society of Australia & New Zealand | Algemeen Directeur | 01-06-2021 |
Anteris Technologies Ltd.
 Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Anteris Technologies Ltd.
Anteris Technologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes technologies for heart valves | Health Technology |
The Pulmonary Hypertension Society of Australia & New Zealand | |
EchoIQ Ltd.
 EchoIQ Ltd. Other Metals/MineralsNon-Energy Minerals Develops and commercializes software products | Non-Energy Minerals |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
